Mechanical thrombectomy in minor stroke due to isolated M2 occlusion: a multicenter retrospective matched analysis.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 22 08 2022
accepted: 29 09 2022
medline: 6 11 2023
pubmed: 13 10 2022
entrez: 12 10 2022
Statut: ppublish

Résumé

The purpose of this study was to evaluate the effectiveness of mechanical thrombectomy (MT) in patients with isolated M2 occlusion and minor symptoms and identify possible baseline predictors of clinical outcome. The databases of 16 high-volume stroke centers were retrospectively screened for consecutive patients with isolated M2 occlusion and a baseline National Institutes of Health Stroke Scale (NIHSS) score ≤5 who received either early MT (eMT) or best medical management (BMM) with the possibility of rescue MT (rMT) on early neurological worsening. Because our patients were not randomized, we used propensity score matching (PSM) to estimate the treatment effect of eMT compared with the BMM/rMT. The primary clinical outcome measure was a 90-day modified Rankin Scale score of 0-1. 388 patients were initially selected and, after PSM, 100 pairs of patients receiving eMT or BMM/rMT were available for analysis. We found no significant differences in clinical outcome and in safety measures between patients receiving eMT or BMM/rMT. Similar results were also observed after comparison between eMT and rMT. Concerning baseline predicting factors of outcome, the involvement of the M2 inferior branch was associated with a favorable outcome. Our multicenter retrospective analysis has shown no benefit of eMT in minor stroke patients with isolated M2 occlusion over a more conservative therapeutic approach. Although our results must be viewed with caution, in these patients it appears reasonable to consider BMM as the first option and rMT in the presence of early neurological deterioration.

Sections du résumé

BACKGROUND BACKGROUND
The purpose of this study was to evaluate the effectiveness of mechanical thrombectomy (MT) in patients with isolated M2 occlusion and minor symptoms and identify possible baseline predictors of clinical outcome.
METHODS METHODS
The databases of 16 high-volume stroke centers were retrospectively screened for consecutive patients with isolated M2 occlusion and a baseline National Institutes of Health Stroke Scale (NIHSS) score ≤5 who received either early MT (eMT) or best medical management (BMM) with the possibility of rescue MT (rMT) on early neurological worsening. Because our patients were not randomized, we used propensity score matching (PSM) to estimate the treatment effect of eMT compared with the BMM/rMT. The primary clinical outcome measure was a 90-day modified Rankin Scale score of 0-1.
RESULTS RESULTS
388 patients were initially selected and, after PSM, 100 pairs of patients receiving eMT or BMM/rMT were available for analysis. We found no significant differences in clinical outcome and in safety measures between patients receiving eMT or BMM/rMT. Similar results were also observed after comparison between eMT and rMT. Concerning baseline predicting factors of outcome, the involvement of the M2 inferior branch was associated with a favorable outcome.
CONCLUSION CONCLUSIONS
Our multicenter retrospective analysis has shown no benefit of eMT in minor stroke patients with isolated M2 occlusion over a more conservative therapeutic approach. Although our results must be viewed with caution, in these patients it appears reasonable to consider BMM as the first option and rMT in the presence of early neurological deterioration.

Identifiants

pubmed: 36223995
pii: jnis-2022-019557
doi: 10.1136/jnis-2022-019557
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e198-e203

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Andrea M Alexandre (AM)

Neuroradiology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Francesca Colò (F)

Catholic University School of Medicine, Rome, Italy.

Valerio Brunetti (V)

Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Iacopo Valente (I)

Neuroradiology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Giovanni Frisullo (G)

Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Alessandro Pedicelli (A)

Neuroradiology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Luca Scarcia (L)

Catholic University School of Medicine, Rome, Italy.

Claudia Rollo (C)

Catholic University School of Medicine, Rome, Italy.

Anne Falcou (A)

Stroke Unit, University Hospital Policlinico Umberto I, Rome, Italy.

Luca Milonia (L)

Interventional Neuroradiology, University Hospital Policlinico Umberto I, Rome, Italy.

Marco Andrighetti (M)

Stroke Unit, University Hospital Policlinico Umberto I, Rome, Italy.

Mariangela Piano (M)

Neuroradiology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Antonio Macera (A)

Neuroradiology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Christian Commodaro (C)

Neuroradiology Unit, AUSL Romagna, Cesena, Italy.

Maria Ruggiero (M)

Neuroradiology Unit, AUSL Romagna, Cesena, Italy.

Valerio Da Ros (V)

Department of Biomedicine and Prevention, University Hospital of Rome "Tor Vergata", Rome, Italy.

Luigi Bellini (L)

Department of Biomedicine and Prevention, University Hospital of Rome "Tor Vergata", Rome, Italy.

Guido A Lazzarotti (GA)

Neuroradiology Unit, Azienda Ospedaliero Universitaria Pisana (AOUP), Pisa, Italy.

Mirco Cosottini (M)

Neuroradiology Unit, Azienda Ospedaliero Universitaria Pisana (AOUP), Pisa, Italy.

Armando A Caragliano (AA)

Neuroradiology Unit, AOU Policlinico G. Martino, Messina, Italy.

Sergio L Vinci (SL)

Neuroradiology Unit, AOU Policlinico G. Martino, Messina, Italy.

Joseph D Gabrieli (JD)

Neuroradiology Unit, Policlinico Universitario di Padova, Padia, Italy.

Francesco Causin (F)

Neuroradiology Unit, Policlinico Universitario di Padova, Padia, Italy.

Pietro Panni (P)

Interventional Neuroradiology Unit, IRCCS San Raffaele University Hospital, Milan, Italy.

Luisa Roveri (L)

Neurology Unit, IRCCS San Raffaele University Hospital, Milan, Italy.

Nicola Limbucci (N)

Interventional Neurovascular Unit, A.O.U. Careggi, Florence, Italy.

Francesco Arba (F)

Stroke Unit, A.O.U. Careggi, Florence, Italy.

Marco Pileggi (M)

Neuroradiology Unit, Neurocenter of Southern Switzerland-EOC, Lugano, Switzerland.

Giovanni Bianco (G)

Stroke Center, Neurocenter of Southern Switzerland-EOC, Lugano, Switzerland.

Daniele G Romano (DG)

Neuroradiology Unit, AOU S Giovanni di Dio e Ruggi di Aragona, Salerno, Italy.

Francesco Diana (F)

Neuroradiology Unit, AOU S Giovanni di Dio e Ruggi di Aragona, Salerno, Italy.

Vittorio Semeraro (V)

Interventional Radiology Unit, "SS Annunziata" Hospital, Taranto, Italy.

Nicola Burdi (N)

Interventional Radiology Unit, "SS Annunziata" Hospital, Taranto, Italy.

Maria P Ganimede (MP)

Neuroradiology Unit, "SS Annunziata" Hospital, Taranto, Italy.

Emilio Lozupone (E)

Neuroradiology Unit, Vito Fazzi Hospital, Lecce, Italy.

Antonio Fasano (A)

Neurology Unit, Vito Fazzi Hospital, Lecce, Italy.

Elvis Lafe (E)

Neuroradiology Unit, IRCCS Policlinico San Matteo, Pavia, Italy.

Anna Cavallini (A)

Cerebrovascular Diseases Unit, IRCCS Fondazione Mondino, Pavia, Italy.

Riccardo Russo (R)

Neuroradiology Unit, Azienda Ospedaliera Città della Salute e della Scienza, Turin, Italy.

Mauro Bergui (M)

Neuroradiology Unit, Azienda Ospedaliera Città della Salute e della Scienza, Turin, Italy.

Paolo Calabresi (P)

Catholic University School of Medicine, Rome, Italy.
Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Giacomo Della Marca (G)

Catholic University School of Medicine, Rome, Italy.
Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Aldobrando Broccolini (A)

Catholic University School of Medicine, Rome, Italy aldobrando.broccolini@policlinicogemelli.it.
Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH